International Assets Investment Management LLC Boosts Stake in Teleflex Incorporated (NYSE:TFX)

International Assets Investment Management LLC boosted its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 29,127.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,215 shares of the medical technology company's stock after buying an additional 3,204 shares during the period. International Assets Investment Management LLC's holdings in Teleflex were worth $795,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TFX. Oregon Public Employees Retirement Fund increased its holdings in shares of Teleflex by 1.2% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company's stock worth $846,000 after purchasing an additional 46 shares in the last quarter. Crossmark Global Holdings Inc. increased its holdings in shares of Teleflex by 1.9% in the 2nd quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company's stock worth $584,000 after purchasing an additional 53 shares in the last quarter. Empirical Finance LLC increased its holdings in shares of Teleflex by 3.9% in the 1st quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company's stock worth $354,000 after purchasing an additional 58 shares in the last quarter. SRS Capital Advisors Inc. increased its holdings in shares of Teleflex by 0.3% in the 2nd quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company's stock worth $4,107,000 after purchasing an additional 62 shares in the last quarter. Finally, First Trust Direct Indexing L.P. increased its holdings in shares of Teleflex by 6.2% in the 1st quarter. First Trust Direct Indexing L.P. now owns 1,254 shares of the medical technology company's stock worth $284,000 after purchasing an additional 73 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Insider Activity

In other news, Director Stuart A. Randle sold 2,674 shares of the business's stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the transaction, the director now directly owns 5,496 shares in the company, valued at $1,313,159.28. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.43% of the company's stock.

Analyst Ratings Changes

A number of research firms have commented on TFX. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st. Truist Financial reaffirmed a "hold" rating and issued a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Monday. Stephens lifted their price objective on Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada cut their price objective on Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Four analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $259.25.

Teleflex Stock Performance

NYSE TFX traded down $1.58 on Wednesday, hitting $201.92. 638,062 shares of the company traded hands, compared to its average volume of 374,641. The company has a market capitalization of $9.38 billion, a price-to-earnings ratio of 40.14, a P/E/G ratio of 2.12 and a beta of 1.18. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The business's 50 day moving average price is $237.29 and its 200-day moving average price is $223.96. Teleflex Incorporated has a 52-week low of $195.51 and a 52-week high of $257.85.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex's quarterly revenue was up 2.4% compared to the same quarter last year. During the same period in the previous year, the business earned $3.64 earnings per share. Equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.67%. Teleflex's dividend payout ratio (DPR) is presently 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.